Commentary

Commentary on ‘Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease’

  1. Jean L. Raphael1,*,
  2. Brigitta U. Mueller1,2

Article first published online: 22 OCT 2007

DOI: 10.1002/ebch.161

Issue

Evidence‐Based Child Health: A Cochrane Review Journal

Evidence-Based Child Health: A Cochrane Review Journal

Special Issue: Poverty and Human Development

Volume 2, Issue 3, pages 1012–1013, September 2007

Additional Information

How to Cite

Raphael, J. L. and Mueller, B. U. (2007), Commentary on ‘Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease’. Evidence-Based Child Health: A Cochrane Review Journal, 2: 1012–1013. doi: 10.1002/ebch.161

Author Information

  1. 1

    Baylor College of Medicine, Houston, Texas, USA

  2. 2

    Texas Children's Cancer Center and Hematology Service, Houston, Texas, USA

*Assistant Professor of Pediatrics, Academic General Pediatrics, Hematology/Oncology, Baylor College of Medicine, Suite 1540.00, Texas Children's Hospital, 6621 Fannin Street, Houston, TX 77030, USA

Publication History

  1. Issue published online: 22 OCT 2007
  2. Article first published online: 22 OCT 2007

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (62K)

Abstract

This is a commentary on a Cochrane review, published in this issue of EBCH, first published as: Hirst C, Owusu-Ofori S. Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease. Cochrane Database of Systematic Reviews 2002, Issue 3. Art. No.: CD003427. DOI: 10.1002/14651858.CD003427.

Further information for this Cochrane review is available in this issue of EBCH in the accompanying EBCH Summary and Characteristics and Key Findings Tables articles. Copyright © 2007 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. The Cochrane Collaboration

View Full Article (HTML) Get PDF (62K)